Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up.
Derk C F KlatteBas BoekestijnMartin N J M WasserShirin Feshtali ShahbaziIsaura S IbrahimJ Sven D MieogSaskia A C LuelmoHans MorreauThomas P PotjerAkin IndersonJurjen J BoonstraFriedo W DekkerHans F A VasenJeanin E van HooftBert A BonsingMonique E van LeerdamPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
. This provides evidence that surveillance in such a high-risk population leads to detection of early-stage PDAC with improved resectability and survival.